APIChangelogInfo
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-
Stock
Insider transactions
CORMEDIX
tastytradeTrade CRMD
CRMD Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-4048121620025k50k75k100k125k150k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-04-02
2025-04-03
LEFKOWITZ STEVEN
M - Exercise
Common Stock
20,000
$4.00
80,000
1
$843.06M
2025-04-02
2025-04-03
LEFKOWITZ STEVEN
M - Exercise
Stock Option (Right to Buy Common Stock)
-20,000
$0.00
1
$843.06M
2025-04-01
2025-04-02
TODISCO JOSEPH
Chief Executive Officer
M - Exercise
Common Stock
59,170
$3.00
178K
1
$843.06M
2025-04-01
2025-04-02
TODISCO JOSEPH
Chief Executive Officer
M - Exercise
Stock Option (Right to Buy Common Stock)
-59,170
$0.00
1
$843.06M
2025-04-01
2025-04-02
TODISCO JOSEPH
Chief Executive Officer
M - Exercise
Stock Option (Right to Buy Common Stock)
-59,170
$0.00
1
$843.06M
2025-04-01
2025-04-02
TODISCO JOSEPH
Chief Executive Officer
M - Exercise
Common Stock
59,170
$3.00
178K
1
$843.06M
2025-01-17
2025-01-22
DUNCAN GREGORY SCOTT
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
DUNTON ALAN
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
LEFKOWITZ STEVEN
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
STEWART ROBERT
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Common Stock
188K
$0.00
1
$843.06M
2025-01-17
2025-01-22
TODISCO JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-23,977
$12.00
-288K
1
$843.06M
2025-01-17
2025-01-22
LEFKOWITZ STEVEN
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
STEWART ROBERT
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Common Stock
188K
$0.00
1
$843.06M
2025-01-17
2025-01-22
TODISCO JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-23,977
$12.00
-288K
1
$843.06M
2025-01-17
2025-01-22
KAPLAN MYRON
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
DILLIONE JANET
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
DUNCAN GREGORY SCOTT
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
DUNTON ALAN
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
KAPLAN MYRON
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-17
2025-01-22
DILLIONE JANET
A - Grant
Common Stock
25,000
$0.00
1
$843.06M
2025-01-10
2025-01-14
DAVID MATTHEW
Chief Financial Officer
F - Tax
Common Stock
-6,515
$11.00
-71,665
1
$843.06M
2025-01-10
2025-01-14
HURLBURT ELIZABETH
EVP
F - Tax
Common Stock
-5,790
$11.00
-63,690
1
$843.06M
2025-01-10
2025-01-14
MISTRY ERIN
EVP, Chief Commercial Officer
F - Tax
Common Stock
-5,689
$11.00
-62,579
1
$843.06M
2025-01-10
2025-01-14
TODISCO JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-17,829
$11.00
-196K
1
$843.06M
2025-01-02
2025-01-06
HURLBURT ELIZABETH
EVP
A - Grant
Common Stock
87,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
DAVID MATTHEW
Chief Financial Officer
A - Grant
Common Stock
62,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
HURLBURT ELIZABETH
EVP
A - Grant
Common Stock
87,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
MISTRY ERIN
EVP, Chief Commercial Officer
A - Grant
Common Stock
62,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
ZELNICK KAUFMAN BETH
Chief Legal Officer
A - Grant
Common Stock
87,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
DAVID MATTHEW
Chief Financial Officer
A - Grant
Common Stock
62,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
MISTRY ERIN
EVP, Chief Commercial Officer
A - Grant
Common Stock
62,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
ZELNICK KAUFMAN BETH
Chief Legal Officer
A - Grant
Common Stock
87,500
$0.00
1
$843.06M
2025-01-02
2025-01-06
DAVID MATTHEW
Chief Financial Officer
F - Tax
Common Stock
-8,648
$8.00
-69,184
1
$843.06M
2025-01-02
2025-01-06
HURLBURT ELIZABETH
EVP
F - Tax
Common Stock
-11,378
$8.00
-91,024
1
$843.06M
2025-01-02
2025-01-06
MISTRY ERIN
EVP, Chief Commercial Officer
F - Tax
Common Stock
-7,830
$8.00
-62,640
1
$843.06M
2025-01-02
2025-01-06
ZELNICK KAUFMAN BETH
Chief Legal Officer
F - Tax
Common Stock
-11,844
$8.00
-94,752
1
$843.06M
2025-01-02
2025-01-06
DAVID MATTHEW
Chief Financial Officer
F - Tax
Common Stock
-8,648
$8.00
-69,184
1
$843.06M
2025-01-02
2025-01-06
HURLBURT ELIZABETH
EVP
F - Tax
Common Stock
-11,378
$8.00
-91,024
1
$843.06M
2025-01-02
2025-01-06
MISTRY ERIN
EVP, Chief Commercial Officer
F - Tax
Common Stock
-7,830
$8.00
-62,640
1
$843.06M
2025-01-02
2025-01-06
ZELNICK KAUFMAN BETH
Chief Legal Officer
F - Tax
Common Stock
-11,844
$8.00
-94,752
1
$843.06M
2024-12-12
2024-12-18
ZELNICK KAUFMAN BETH
Chief Legal Officer
F - Tax
Common Stock
-6,044
$9.00
-54,396
1
$843.06M
2024-12-12
2024-12-16
ZELNICK KAUFMAN BETH
Chief Legal Officer
M - Exercise
Restricted Stock Units
-12,500
$0.00
1
$843.06M
2024-12-12
2024-12-16
ZELNICK KAUFMAN BETH
Chief Legal Officer
M - Exercise
Common Stock
12,500
1
$843.06M
2024-12-12
2024-12-16
ZELNICK KAUFMAN BETH
Chief Legal Officer
F - Tax
Common Stock
-6,044
$9.00
-54,396
1
$843.06M
2024-10-31
2024-12-13
MISTRY ERIN
EVP, Chief Commercial Officer
P - Purchase
Common Stock
1,500
$10.00
15,000
1
$843.06M
2024-11-14
2024-11-18
HURLBURT ELIZABETH
EVP
M - Exercise
Stock Option (Right to Buy Common Stock)
-140K
$0.00
6
$843.06M
2024-11-14
2024-11-18
HURLBURT ELIZABETH
EVP
M - Exercise
Common Stock
140K
$4.00
560K
6
$843.06M
2024-11-14
2024-11-18
HURLBURT ELIZABETH
EVP
S - Sale
Common Stock
-140K
$11.00
-1.54M
1
$843.06M
2024-05-10
2024-05-13
TODISCO JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-26,982
$5.00
-135K
1
$843.06M
2024-03-05
2024-03-20
DILLIONE JANET
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2024-03-05
2024-03-20
DUNCAN GREGORY SCOTT
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2024-03-05
2024-03-20
DUNTON ALAN
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2024-03-05
2024-03-20
KAPLAN MYRON
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2024-03-05
2024-03-20
LEFKOWITZ STEVEN
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2024-03-05
2024-03-20
STEWART ROBERT
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2024-03-13
2024-03-14
TODISCO JOSEPH
Chief Executive Officer
P - Purchase
Common Stock
13,561
$4.00
54,244
1
$843.06M
2024-01-12
2024-01-17
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
F - Tax
Common Stock
-4,603
$3.00
-13,809
1
$843.06M
2024-01-12
2024-01-17
DAVID MATTHEW
Chief Financial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2024-01-12
2024-01-17
DAVID MATTHEW
Chief Financial Officer
A - Grant
Common Stock
50,000
$0.00
1
$843.06M
2024-01-12
2024-01-17
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2024-01-12
2024-01-17
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Common Stock
50,000
$0.00
1
$843.06M
2024-01-12
2024-01-17
MISTRY ERIN
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2024-01-12
2024-01-17
MISTRY ERIN
Chief Commercial Officer
A - Grant
Common Stock
50,000
$0.00
1
$843.06M
2024-01-12
2024-01-17
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Stock Option (Right to Buy Common Stock)
267K
$0.00
1
$843.06M
2024-01-12
2024-01-17
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Common Stock
133K
$0.00
1
$843.06M
2024-01-12
2024-01-17
DAVID MATTHEW
Chief Financial Officer
F - Tax
Common Stock
-5,216
$3.00
-15,648
1
$843.06M
2024-01-12
2024-01-17
MISTRY ERIN
Chief Commercial Officer
F - Tax
Common Stock
-4,389
$3.00
-13,167
1
$843.06M
2024-01-12
2024-01-17
TODISCO JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-13,781
$3.00
-41,343
1
$843.06M
2023-12-15
2023-12-18
DUNTON ALAN
P - Purchase
Common Stock
3,000
$3.00
9,000
1
$843.06M
2023-12-14
2023-12-18
DUNTON ALAN
P - Purchase
Common Stock
3,000
$3.00
9,000
1
$843.06M
2023-12-12
2023-12-14
ZELNICK KAUFMAN BETH
Chief Legal Officer
A - Grant
Stock Option (Right to Buy Common Stock)
200K
$0.00
1
$843.06M
2023-12-12
2023-12-14
ZELNICK KAUFMAN BETH
Chief Legal Officer
A - Grant
Common Stock
50,000
$0.00
1
$843.06M
2023-11-17
2023-11-21
MISTRY ERIN
Chief Commercial Officer
P - Purchase
Common Stock
1,000
$4.00
4,000
1
$843.06M
2023-11-16
2023-11-17
LEFKOWITZ STEVEN
M - Exercise
Common Stock
15,000
$2.00
30,000
1
$843.06M
2023-11-16
2023-11-17
LEFKOWITZ STEVEN
M - Exercise
Stock Option (Right to Buy Common Stock)
-15,000
$0.00
1
$843.06M
2023-09-08
2023-09-08
TODISCO JOSEPH
Chief Executive Officer
P - Purchase
Common Stock
10,000
$4.00
40,000
1
$843.06M
2023-05-18
2023-05-19
KAPLAN MYRON
P - Purchase
Common Stock
6,000
$5.00
30,000
1
$843.06M
2023-05-17
2023-05-18
COSTA PAULO
P - Purchase
Common Stock
10,000
$5.00
50,000
1
$843.06M
2023-05-17
2023-05-18
DUNTON ALAN
P - Purchase
Common Stock
3,000
$4.00
12,000
1
$843.06M
2023-05-17
2023-05-18
STEWART ROBERT
P - Purchase
Common Stock
10,000
$4.00
40,000
1
$843.06M
2023-05-17
2023-05-18
TODISCO JOSEPH
Chief Executive Officer
P - Purchase
Common Stock
5,000
$5.00
25,000
1
$843.06M
2023-05-17
2023-05-17
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Common Stock
5,000
$5.00
25,000
1
$843.06M
2023-05-17
2023-05-17
COSTA PAULO
A - Grant
Common Stock
10,000
$5.00
50,000
1
$843.06M
2023-05-17
2023-05-17
DUNTON ALAN
A - Grant
Common Stock
3,000
$4.00
12,000
1
$843.06M
2023-05-17
2023-05-17
STEWART ROBERT
A - Grant
Common Stock
10,000
$4.00
40,000
1
$843.06M
2023-05-10
2023-05-12
TODISCO JOSEPH
Chief Executive Officer
F - Tax
Common Stock
-37,443
$5.00
-187K
1
$843.06M
2023-04-13
2023-04-17
STEWART ROBERT
A - Grant
Stock Option (Right to Buy Common Stock)
39,200
$0.00
2
$843.06M
2023-01-14
2023-01-20
MISTRY ERIN
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
75,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
DILLIONE JANET
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
DUNCAN GREGORY SCOTT
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
DUNTON ALAN
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
KAPLAN MYRON
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Stock Option (Right to Buy Common Stock)
125K
$0.00
1
$843.06M
2023-01-14
2023-01-18
MOUNTS PHOEBE
General Counsel
A - Grant
Stock Option (Right to Buy Common Stock)
125K
$0.00
1
$843.06M
2023-01-14
2023-01-18
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Stock Option (Right to Buy Common Stock)
400K
$0.00
1
$843.06M
2023-01-14
2023-01-18
LEFKOWITZ STEVEN
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
COSTA PAULO
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2023-01-14
2023-01-18
DAVID MATTHEW
Chief Financial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
125K
$0.00
1
$843.06M
2022-11-15
2022-11-16
TODISCO JOSEPH
Chief Executive Officer
P - Purchase
Common Stock
20,000
$4.00
80,000
1
$843.06M
2022-08-24
2022-08-25
TODISCO JOSEPH
Chief Executive Officer
P - Purchase
Common Stock
4,700
$4.00
18,800
1
$843.06M
2022-05-17
2022-05-18
KAPLAN MYRON
P - Purchase
Common Stock
5,000
$4.00
20,000
1
$843.06M
2022-05-16
2022-05-17
TODISCO JOSEPH
Chief Executive Officer
P - Purchase
Common Stock
10,000
$3.00
30,000
1
$843.06M
2022-05-10
2022-05-12
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Stock Option (Right to Buy Common Stock)
500K
$0.00
1
$843.06M
2022-05-10
2022-05-12
TODISCO JOSEPH
Chief Executive Officer
A - Grant
Common Stock
207K
$0.00
1
$843.06M
2022-02-22
2022-02-23
DILLIONE JANET
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2022-02-22
2022-02-23
DUNTON ALAN
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2022-02-22
2022-02-23
KAPLAN MYRON
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2022-02-22
2022-02-23
LEFKOWITZ STEVEN
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2022-02-22
2022-02-23
COSTA PAULO
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2022-02-22
2022-02-23
DUNCAN GREGORY SCOTT
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2022-02-18
2022-02-23
DAVID MATTHEW
Interim CEO and CFO
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2022-02-18
2022-02-23
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2022-02-18
2022-02-23
MOUNTS PHOEBE
General Counsel
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$843.06M
2022-02-18
2022-02-23
NUSBICKEL THOMAS
EVP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2021-12-27
2021-12-29
KAPLAN MYRON
G - Gift
Common Stock
-35,000
$0.00
4
$843.06M
2021-12-06
2021-12-07
DAVID MATTHEW
Interim CEO and CFO
P - Purchase
Common Stock
1,000
$5.00
5,000
1
$843.06M
2021-11-17
2021-11-19
DAVID MATTHEW
Interim CEO and CFO
P - Purchase
Common Stock
1,000
$5.00
5,000
1
$843.06M
2021-11-16
2021-11-19
KAPLAN MYRON
P - Purchase
Common Stock
10,000
$5.00
50,000
1
$843.06M
2021-11-01
2021-11-10
DAVID MATTHEW
Interim CEO and CFO
A - Grant
Stock Option (Right to Buy Common Stock)
125K
$0.00
1
$843.06M
2021-11-01
2021-11-03
MOUNTS PHOEBE
General Counsel
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$0.00
1
$843.06M
2021-05-21
2021-05-25
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops
S - Sale
Common Stock
-8,000
$7.00
-56,000
1
$843.06M
2021-05-13
2021-05-20
NUSBICKEL THOMAS
EVP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
268K
$0.00
2
$843.06M
2021-05-17
2021-05-19
KAPLAN MYRON
P - Purchase
Common Stock
15,000
$6.00
90,000
1
$843.06M
2021-01-11
2021-01-13
DUNCAN GREGORY SCOTT
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
ARMSTRONG JR. JOHN
Exec VP of Tech Operations
A - Grant
Stock Option (Right to Buy Common Stock)
140K
$0.00
1
$843.06M
2021-01-11
2021-01-13
BALUCH KHOSO
Chief Executive Officer
A - Grant
Stock Option (Right to Buy Common Stock)
320K
$0.00
1
$843.06M
2021-01-11
2021-01-13
COSTA PAULO
A - Grant
Stock Option (Right to Buy Common Stock)
20,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
DAVID MATTHEW
Chief Financial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
80,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
DILLIONE JANET
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
DUNTON ALAN
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
KAPLAN MYRON
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
LEFKOWITZ STEVEN
A - Grant
Stock Option (Right to Buy Common Stock)
30,000
$0.00
1
$843.06M
2021-01-11
2021-01-13
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Stock Option (Right to Buy Common Stock)
140K
$0.00
1
$843.06M
2021-01-11
2021-01-13
MOUNTS PHOEBE
General Counsel
A - Grant
Stock Option (Right to Buy Common Stock)
140K
$0.00
1
$843.06M
2020-11-16
2020-11-18
DILLIONE JANET
A - Grant
Phantom Stock
3,583
$0.00
1
$843.06M
2020-11-02
2020-11-04
DUNCAN GREGORY SCOTT
A - Grant
Stock Option (Right to Buy Common Stock)
22,500
$0.00
2
$843.06M
2020-09-15
2020-09-17
COSTA PAULO
A - Grant
Stock Option (Right to Buy Common Stock)
23,750
$0.00
2
$843.06M
2020-09-04
2020-09-09
LEFKOWITZ STEVEN
P - Purchase
Common Stock
5,715
$4.00
22,860
2
$843.06M
2020-09-03
2020-09-08
DAVID MATTHEW
Chief Financial Officer
P - Purchase
Common Stock
1,150
$4.00
4,600
1
$843.06M
2020-09-02
2020-09-04
KAPLAN MYRON
P - Purchase
Common Stock
15,300
$4.00
61,200
1
$843.06M
2020-08-19
2020-08-20
KHAN MEHMOOD
P - Purchase
Common Stock
17,837
$5.00
89,185
2
$843.06M
2020-08-18
2020-08-20
KHAN MEHMOOD
P - Purchase
Common Stock
27,913
$5.00
140K
3
$843.06M
2020-08-14
2020-08-17
ARMSTRONG JR. JOHN
Exec VP of Tech Operations
P - Purchase
Common Stock
27,500
$4.00
110K
3
$843.06M
2020-08-14
2020-08-17
DILLIONE JANET
A - Grant
Phantom Stock
4,770
$0.00
1
$843.06M
2020-08-13
2020-08-17
BALUCH KHOSO
Chief Executive Officer
P - Purchase
Common Stock
4,830
$4.00
19,320
1
$843.06M
2020-08-13
2020-08-17
KAPLAN MYRON
P - Purchase
Common Stock
15,000
$4.00
60,000
1
$843.06M
2020-08-13
2020-08-17
MOUNTS PHOEBE
General Counsel
P - Purchase
Common Stock
2,525
$4.00
10,100
1
$843.06M
2020-08-12
2020-08-14
DUNTON ALAN
P - Purchase
Common Stock
5,000
$4.00
20,000
1
$843.06M
2020-05-15
2020-05-18
DILLIONE JANET
A - Grant
Phantom Stock
5,253
$0.00
1
$843.06M
2020-05-15
2020-05-18
KAPLAN MYRON
P - Purchase
Common Stock
10,000
$4.00
40,000
1
$843.06M
2020-05-11
2020-05-13
MASSON-HURLBURT ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Stock Option (Right to Buy Common Stock)
75,000
$5.00
375K
2
$843.06M
2020-05-11
2020-05-13
ARMSTRONG JR. JOHN
Exec VP of Tech Operations
A - Grant
Stock Option (Right to Buy Common Stock)
75,000
$5.00
375K
2
$843.06M
2020-05-11
2020-05-13
DAVID MATTHEW
EVP, Chief Financial Officer
A - Grant
Stock Option (Right to Buy Common Stock)
250K
$5.00
1.25M
2
$843.06M
2020-05-11
2020-05-13
MOUNTS PHOEBE
General Counsel
A - Grant
Stock Option (Right to Buy Common Stock)
100K
$5.00
500K
2
$843.06M
2020-03-18
2020-03-19
MOUNTS PHOEBE
General Counsel
P - Purchase
Common Stock
3,250
$3.00
9,750
1
$843.06M
2020-03-18
2020-03-18
BALUCH KHOSO
Chief Executive Officer
P - Purchase
Common Stock
3,500
$3.00
10,500
1
$843.06M
2020-02-25
2020-02-27
KAPLAN MYRON
A - Grant
Stock Option (Right to Buy Common Stock)
15,000
$6.00
90,000
1
$843.06M
2020-02-25
2020-02-27
DILLIONE JANET
A - Grant
Stock Option (Right to Buy Common Stock)
15,000
$6.00
90,000
1
$843.06M
2020-02-25
2020-02-27
DUNTON ALAN
A - Grant
Stock Option (Right to Buy Common Stock)
15,000
$6.00
90,000
1
$843.06M
2020-02-25
2020-02-27
KHAN MEHMOOD
A - Grant
Stock Option (Right to Buy Common Stock)
15,000
$6.00
90,000
1
$843.06M
2020-02-25
2020-02-27
LEFKOWITZ STEVEN
A - Grant
Stock Option (Right to Buy Common Stock)
15,000
$6.00
90,000
1
$843.06M
2020-02-25
2020-02-27
MASSON ELIZABETH
EVP, Head of Clinical Ops.
A - Grant
Stock Option (Right to Buy Common Stock)
24,764
$6.00
149K
1
$843.06M
2020-02-25
2020-02-27
MOUNTS PHOEBE
General Counsel
A - Grant
Stock Option (Right to Buy Common Stock)
24,764
$6.00
149K
1
$843.06M
2020-02-25
2020-02-27
ARMSTRONG JR. JOHN
Exec VP of Tech Operations
A - Grant
Stock Option (Right to Buy Common Stock)
24,764
$6.00
149K
1
$843.06M
2020-02-25
2020-02-27
BALUCH KHOSO
Chief Executive Officer
A - Grant
Stock Option (Right to Buy Common Stock)
101K
$6.00
604K
1
$843.06M
2020-01-07
2020-02-27
LEFKOWITZ STEVEN
X - Exercise
Common Stock
7,500
$5.00
37,500
2
$843.06M
2020-01-07
2020-02-27
LEFKOWITZ STEVEN
X - Exercise
Warrant (Right to Purchase Common Stock)
7,500
$5.00
37,500
2
$843.06M
2020-02-14
2020-02-20
DILLIONE JANET
A - Grant
Phantom Stock
1,706
$0.00
1
$843.06M
2020-02-14
2020-02-19
DILLIONE JANET
A - Grant
Phantom Stock
1,706
$0.00
1
$843.06M
2019-12-30
2020-01-02
MOUNTS PHOEBE
General Counsel
P - Purchase
Common Stock
1,425
$7.00
9,975
1
$843.06M
2019-12-13
2019-12-17
KHAN MEHMOOD
P - Purchase
Common Stock
17,000
$7.00
119K
1
$843.06M